Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

Duration of DAPT Therapy With Contemporary DES (Including BVS)

Presenter: Alejandro Cherro, Anibal A. Damonte, Alfredo E. Rodriguez, Gustavo A Samaja

October 31, 2016

Presentation TVT 2016

Will General Anesthesia Be Needed for Valve Therapy?

Presenter: Douglas C Shook

June 18, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation Fellows 2016

The TAVR Revolution: The Future of Aortic Stenosis Therapy

Presenter: Mark Reisman, Susheel Kodali

April 17, 2016

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

Gene Therapy for CHF

Presenter: Henricus J. Duckers, Bernard J. Gersh, Gary L. Schaer

October 14, 2015

Presentation

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

Presenter: ES. Chung

June 22, 2015

Presentation TVT 2015

3M for Alternative Access TAVR? Early Experience and Next Steps

Presenter: Sandra Lauck, David A. Wood, Philippe Genereux

June 06, 2015

Presentation TVT 2015

Should All Repositionable Valves Have Intraprocedural TEE?

Presenter: Ian T. Meredith

June 06, 2015

Presentation TVT 2015

Impact of Second-Generation TAVR on Preprocedural Imaging

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Presenter: Rebecca T. Hahn

June 06, 2015

Presentation TVT 2015

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Presenter: Jean Buitheiu

June 06, 2015

Presentation TVT 2015

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

Presenter: Jeffrey J. Popma

June 06, 2015

Presentation TVT 2015

When Do We Take the LVOT Into Account in Device Sizing and Why

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

The Best Point in RR to Measure and Why

Presenter: Jonathon A. Leipsic

June 06, 2015

Presentation TVT 2015

CT Guidance for Valve Selection: Balloon-Expandable vs Self-Expanding Valves

Presenter: Danny Dvir

June 06, 2015

Presentation TVT 2015

CT Guidance in Selecting Valve Size When at the Extremes of the Sizing Algorithm: Go Big or Go Small

Presenter: Philipp Blanke

June 06, 2015

Presentation TVT 2015

Area vs Perimeter: What Is the Rationale Between the Edwards and CoreValve Sizing Methods?

Presenter: Jonathon A. Leipsic

June 06, 2015

Presentation TVT 2015

Nuances of Preprocedure TEE That Can Provide Guidance for TAVR Success/Challenge

Presenter: Rebecca T. Hahn

June 06, 2015

Advertisement

Beyond Cells: Cardiac Gene Therapy In Perspective

Duration of DAPT Therapy With Contemporary DES (Including BVS)

Will General Anesthesia Be Needed for Valve Therapy?

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

The TAVR Revolution: The Future of Aortic Stenosis Therapy

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Gene Therapy for CHF

STOP HF: Changes in Ventricular Remodeling and Clinical Status During the Year After SDF-1 Gene Therapy in Chronic Ischemic Heart Failure Patients

3M for Alternative Access TAVR? Early Experience and Next Steps

Should All Repositionable Valves Have Intraprocedural TEE?

Impact of Second-Generation TAVR on Preprocedural Imaging

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

When Do We Take the LVOT Into Account in Device Sizing and Why

The Best Point in RR to Measure and Why

CT Guidance for Valve Selection: Balloon-Expandable vs Self-Expanding Valves

CT Guidance in Selecting Valve Size When at the Extremes of the Sizing Algorithm: Go Big or Go Small

Area vs Perimeter: What Is the Rationale Between the Edwards and CoreValve Sizing Methods?

Nuances of Preprocedure TEE That Can Provide Guidance for TAVR Success/Challenge

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content